Latest Market News
USDCAD, “US Dollar vs Canadian Dollar” As we can see in the H4 chart, after forming a Hanging Man reversal pattern close to the resistance level, USDCAD may reverse in the form of a new descending wave. In this case, the downside correctional target may be at 1.3745. Later, the market may rebound from the […]
Barclays lifted its expectations for the next few rate hikes by the Federal Reserve on Thursday following September’s hotter-than-expected consumer-price-index report. The firm now expects 75 basis point rate hikes each at the Fed’s November and December meetings, versus a prior expectation for a 50-basis-point move in the final month of the year, according to […]
Traders see a 42.6% likelihood that the fed-funds rate target will get to between 5% and 5.25%, or even higher, by next March after Thursday’s hotter-than-expected consumer-price index report for September. That’s up from 6.1% on Wednesday, according to the CME FedWatch Tool. The CPI report also cemented a 95.8% chance of a 75-basis-point rate […]
U.S. stocks opened sharply lower Thursday, with the Dow Jones Industrial Average falling more than 500 points, after the consumer-price index showed that inflation in September was hotter than forecast. The Dow DJIA, +2.31% was down 1.7% soon after the opening bell, while the S&P 500 SPX, +2.22% fell about 2.2% and the Nasdaq Composite […]
Patterson Companies Inc. PDCO, +2.68% said Thursday that is has named Don Zurbay as chief executive officer. Zurbay, who was most recently the dental and animal health company’s chief financial officer, succeeds Mark Walchirk as CEO. Walchirk had resigned from the company, after it was determined that he “violated company policy and demonstrated poor judgment […]
Shares of Relmada Therapeutics Inc. RLMD, -78.23% fell 80.0% in premarket trading on Thursday after the biotech said its experimental treatment for major depressive disorder as a monotherapy did not meet the primary endpoint in a Phase 3 clinical trial. The company said it is still enrolling patients in two other late-stage studies assessing the […]